Pure Global
NCT05894460

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion: a Single-centre, Prospective Observational Study
Xuanwu Hospital, Beijing·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peripheral Arterial Disease
Drug/Device/Intervention
Chocolate balloon
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Xuanwu Hospital, Beijing
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Jun 27, 2023
End date
Dec 31, 2024
Enrollment
254 participants
Primary outcome

Primary patency

Summary

This study will assess the safety and efficacy of Chocolate balloons as a combination with
 drug-coated balloons in the treatment of popliteal artery lesions in lower limb
 atherosclerotic occlusive disease and will compare them with conventional balloons.

ICD-10 classifications
Peripheral vascular disease, unspecifiedOther peripheral vascular diseasesOther specified peripheral vascular diseasesPeripheral angiopathy in diseases classified elsewhereOther congenital malformations of peripheral vascular system
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05894460
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05894460 through Pure Global AI's free database. This phase not specified trial is sponsored by Xuanwu Hospital, Beijing and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 254 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.